Reduced inotropic support after aprotinin therapy during pediatric cardiac operations Carl F Wippermann, MD, Franz X Schmid, MD, Balthasar Eberle, MD,

Slides:

Advertisements

Similar presentations

Impact of cardiac surgery using cardiopulmonary bypass on course of chronic lymphatic leukemia: a case-control study Evgenij V Potapov, MD, Heinz R Zurbrügg,

Advertisements

The effect of cardiotomy suction on the brain injury marker S100β after cardiopulmonary bypass Russell E Anderson, MD, PhD, Lars-Olof Hansson, MD, PhD,

Stress-Dose Corticosteroid Versus Placebo in Neonatal Cardiac Operations: A Randomized Controlled Trial Pertti K. Suominen, MD, PhD, Juho Keski-Nisula,

Postconditioning the Human Heart with Adenosine in Heart Valve Replacement Surgery Zhen-Xiao Jin, MD, Jing-Jun Zhou, PhD, Mei Xin, MS, Dao-Rong Peng,

Antithrombin Administration in Patients With Low Antithrombin Values After Cardiac Surgery: A Randomized Controlled Trial Domenico Paparella, MD, Crescenzia.

Postoperative use of aprotinin in cardiac operations: An alternative to its prophylactic use Sertaç Ciçek, MD*, Ufuk Demirkiliç, MD, Ertugrul Özal, MD,

Phosphorylcholine Coating May Limit Thrombin Formation During High-Risk Cardiac Surgery: A Randomized Controlled Trial Federico Pappalardo, MD, Patrizia.

Cumulative Corticosteroid Exposure and Infection Risk After Complex Pediatric Cardiac Surgery Christopher W. Mastropietro, MD, Renee Barrett, MD, Maria.

Long-Term Outcome of Coronary Artery Bypass Grafting in Patients With Left Ventricular Dysfunction Paolo Nardi, MD, PhD, Antonio Pellegrino, MD, Antonio.

Risk-Adjusted Prolonged Length of Stay as an Alternative Outcome Measure for Pediatric Congenital Cardiac Surgery Ming Liu, MS, MA, Charlotte M. Druschel,

Treatment of a persistent postoperative chylothorax with somatostatin

Warfarin Cessation Before Cardiopulmonary Bypass: Lessons Learned from a Randomized Controlled Trial of Oral Vitamin K Richard P. Whitlock, MD, Mark.

Effect of hemofiltrated whole blood pump priming on hemodynamics and respiratory function after the arterial switch operation in neonates Mitsugi Nagashima,

Prospective, Randomized, Double-Blind Study of High-Dose Aprotinin in Pediatric Cardiac Operations Michael J Davies, FRCS, Alison Allen, BScHons, Henry.

James L Zellner, MD, Scott B Kribbs, BS, B

Influence of perioperative factors on outcomes in children younger than 18 months after repair of tetralogy of Fallot Umesh Dyamenahalli, MD, Brian W.

Cardiac Operations in Solid-Organ Transplant Recipients

Leukocyte depletion during cardiac operation: a new approach through the venous bypass circuit Y.John Gu, MD, PhD, A.J de Vries, MD, Paulien Vos, Piet.

Sivelestat Attenuates Lung Injury in Surgery for Congenital Heart Disease With Pulmonary Hypertension Norikazu Nomura, MD, PhD, Miki Asano, MD, PhD,

Metabolic and Hemodynamic Effects of High-Dose Insulin Treatment in Aortic Valve and Coronary Surgery Juha K. Koskenkari, MD, Päivi K. Kaukoranta, MD,

Chest Reexploration in the Intensive Care Unit After Cardiac Surgery: A Safe Alternative to Returning to the Operating Theater Charalambos P. Charalambous,

François Dagenais, MD, L.Conrad Pelletier, MD, Michel Carrier, MD

Temporary Atrial Electrode for the Treatment of Supraventricular Tachycardia After Cardiac Operations Hormoz Mehmanesh, Rüdiger Lange, Siegfried Hagl

Use of an Adjustable Tourniquet to Reverse Cyanosis in the Newborn Pig

Aprotinin in pediatric cardiac operations: a benefit in complex malformations and with high-dose regimen only Thierry P Carrel, MD, Mike Schwanda, MD,

Magnesium-supplemented warm blood cardioplegia in patients undergoing coronary artery revascularization Mark Yeatman, Massimo Caputo, MD, Pradeep Narayan,

Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD

Cardiac pacing in premature infants and neonates: steroid eluting leads and automatic output adaptation Franz X Schmid, MD, Bernd Nowak, MD, Christoph.

An Analysis of Oxygen Consumption and Oxygen Delivery in Euthermic Infants After Cardiopulmonary Bypass With Modified Ultrafiltration Jia Li, MD, PhD,

Central venous catheter use in low-risk coronary artery bypass grafting Robert D Stewart, MD, Triffin Psyhojos, MD, Stephen J Lahey, MD, Sidney Levitsky,

Initial Clinical Experience With the Symphony Heart Assist System

Farkas Vánky, MD, Mats Broquist, MD, PhD, Rolf Svedjeholm, MD, PhD

Damien J. LaPar, MD, MS, James M. Isbell, MD, MSCI, Daniel P

Stress-Dose Corticosteroid Versus Placebo in Neonatal Cardiac Operations: A Randomized Controlled Trial Pertti K. Suominen, MD, PhD, Juho Keski-Nisula,

John S. Ikonomidis, MD, PhD, Ebony J

Surgical Dilemmas: Diagnosis and Treatment of Atrial Plasmacytoma

Torsten Doenst, MD, Wolfgang Bothe, MD, Friedhelm Beyersdorf, MD

Early postoperative body temperature and developmental outcome after open heart surgery in infants Serena M Cottrell, MRCPCH, Kevin P Morris, MD, Paul.

Antithrombin Administration in Patients With Low Antithrombin Values After Cardiac Surgery: A Randomized Controlled Trial Domenico Paparella, MD, Crescenzia.

Adenosine instead of supranormal potassium in cardioplegia: It is safe, efficient, and reduces the incidence of postoperative atrial fibrillation. A randomized.

Biventricular repair in neonates with hypoplastic left heart complex

Repair of aortic coarctation in patients more than 50 years of age

Russel Hirsch, Catherine L. Dent, Mary K. Wood, Charles B

Editorial Board, January 2010

Sarah C. Huen, MD, Chirag R. Parikh, MD, PhD

Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery Julio C Vasquez, MD, Anna Vichiendilokkul, PharmD, Syed Mahmood, MD,

Surgical-Interventional Hybrid Concept in a Newborn With Borderline Left Heart Stefan Rupp, MD, Josef Thul, MD, Kerstin Gummel, MD, Markus Khalil, MD,

Time course of proinflammatory and anti-inflammatory responses after cardiac operation: monocyte HLA-DR expression Y.John Gu, MD, PhD, Willem van Oeveren,

Adjustable tourniquet to manipulate pulmonary blood flow after Norwood operations Franz X Schmid, MD, Christoph Kampmann, MD, Wlodimierz Kuroczynski,

Tachyarrhythmias and triggering factors for atrial fibrillation after coronary artery bypass operations Lena Jidéus, MD, Per Blomström, MD, PhD, Leif.

Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion Kiyotaka Fukamachi, MD, PhD, Patrick.

Aprotinin Enhances the Endogenous Release of Interleukin-10 After Cardiac Operations Gary E Hill, Robert P Diego, Alfred H Stammers, Suzanne M Huffman,

Comparison of epsilon aminocaproic acid and low-dose aprotinin in cardiopulmonary bypass: efficiency, safety and cost Michael J Ray, PhD, Mark F O’Brien

Aprotinin is Not Associated With Postoperative Renal Impairment After Primary Coronary Surgery Gabriella Lindvall, MD, Ulrik Sartipy, MD, PhD, Torbjörn.

Postoperatively administered aprotinin or epsilon aminocaproic acid after cardiopulmonary bypass has limited benefit Michael J Ray, PhD, Majella M Hales,

Sérgio A de Oliveira, MD The Annals of Thoracic Surgery

Kirk R Kanter, MD, Robert N Vincent, MD, Anthony A Raviele, MD

Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: effects before and after pulmonary thromboendarterectomy Thorsten Kramm,

Prospective Validation of a Novel Vasoactive-Ventilation-Renal Score as a Predictor of Outcomes After Pediatric Cardiac Surgery Kyle G. Miletic, MD,

Treatment of left atrial dissection after mitral repair: internal drainage Michele Genoni, MD, Rolf Jenni, MD, Edith R Schmid, MD, Paul R Vogt, MD, Marko.

Factors influencing intensive care unit length of stay after surgery for acute aortic dissection type A Daniel Hoefer, MD, Elfriede Ruttmann, MD, Markus.

Fibrinolysis-adjusted perioperative low-dose aprotinin reduces blood loss in bypass operations Martin Misfeld, MD, Sven Dubbert, Sawas Eleftheriadis,

The Impact of New Technology on Cardiothoracic Surgical Practice

Reduced Cytokines Release and Myocardial Damage in Coronary Artery Bypass Patients Due to L-Arginine Cardioplegia Supplementation Luisa Colagrande, MD,

Robert J Frumento, MS, MPH, Catherine M

Left Ventricular End-Diastolic Pressure Predicts Survival in Coronary Artery Bypass Graft Surgery Patients Jeevan Nagendran, MD, PhD, Colleen M. Norris,

Short Operation Time: An Important Element to Reduce Operative Invasiveness in Pediatric Cardiac Surgery Makoto Ando, MD, Yukihiro Takahashi, MD, Toshio.

On-pump versus off-pump coronary artery bypass grafting: impact on postoperative renal failure requiring renal replacement therapy Jan Bucerius, MD,

Intravenous milrinone in cardiac surgery

High-Dose ϵ-Aminocaproic Acid Versus Aprotinin: Antifibrinolytic Efficacy in First-Time Coronary Operations Balthasar Eberle, Eckhard Mayer, Gerhard.

Presentation transcript:

Reduced inotropic support after aprotinin therapy during pediatric cardiac operations Carl F Wippermann, MD, Franz X Schmid, MD, Balthasar Eberle, MD, Ralf G Huth, MD, Christoph Kampmann, MD, Dietmar Schranz, MD, Helmut Oelert, MD, PhD The Annals of Thoracic Surgery Volume 67, Issue 1, Pages 173-176 (January 1999) DOI: 10.1016/S0003-4975(98)00974-6

Fig 1 Left atrial pressure (LAP), shortening fraction, cumulative epinephrine dose [μg/kg], and cumulative enoximone dose [mg/kg] on arrival at the intensive care unit (ICU) 6, 12, 24, and 48 hours after weaning from bypass in the aprotinin group (closed circles) and placebo group (open triangles). There were no significant differences between the two groups in LAP and the cumulative epinephrine dose. The shortening fraction in the placebo group was reduced immediately postoperatively but did not reach significance. With the exception of 6 hours after bypass the placebo group received more enoximone. Values are shown as mean ± standard deviation. (ns = not significant; ∗ p < 0.05). The Annals of Thoracic Surgery 1999 67, 173-176DOI: (10.1016/S0003-4975(98)00974-6)